Literature DB >> 7377785

A plasma porphyrin fluorescence marker for variegate porphyria.

M B Poh-Fitzpatrick.   

Abstract

Ten patients with variegate porphyria were uniformly found to have distinctive plasma porphyrin fluorescence wavelength maxima in saline-diluted plasma specimens. The porphyrin complex in each of these plasma samples had a fluorescence emission maximum at 626 +/- 1 nm. Twelve patients with porphyria cutanea tarda, eight patients with erythropoietic protoporphyria, one patient with congenital erythropoietic porphyria, two patients with acute intermittent porphyria, and four patients with hereditary coproporphyria, whose plasma specimens were similarly examined, had plasma fluorescence characteristics that were different from those of the patients with variegate porphyria. Plasma fluorescence emission that is maximal at 626 +/- 1 nm is a diagnostic marker for variegate porphyria.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7377785

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  19 in total

1.  Characterization of mutations in the CPO gene in British patients demonstrates absence of genotype-phenotype correlation and identifies relationship between hereditary coproporphyria and harderoporphyria.

Authors:  J Lamoril; H Puy; S D Whatley; C Martin; J R Woolf; V Da Silva; J C Deybach; G H Elder
Journal:  Am J Hum Genet       Date:  2001-04-16       Impact factor: 11.025

Review 2.  Diagnosis and management of porphyria.

Authors:  H Thadani; A Deacon; T Peters
Journal:  BMJ       Date:  2000-06-17

3.  Celiac disease in patients with variegate porphyria.

Authors:  S Twaddle; W S Wassif; A C Deacon; T J Peters
Journal:  Dig Dis Sci       Date:  2001-07       Impact factor: 3.199

Review 4.  ACP Best Practice No 165: front line tests for the investigation of suspected porphyria.

Authors:  A C Deacon; G H Elder
Journal:  J Clin Pathol       Date:  2001-07       Impact factor: 3.411

Review 5.  [Diagnosis of the porphyrias : From A (as in aminolevulinic acid) to Z (as in zinc protoporphyrin)].

Authors:  V Kürten; N J Neumann; J Frank
Journal:  Hautarzt       Date:  2016-03       Impact factor: 0.751

6.  Hereditary coproporphyria: comparison of molecular and biochemical investigations in a large family.

Authors:  K R Allen; S D Whatley; T J Degg; J H Barth
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

7.  [Laboratory tests and therapeutic strategies for the porphyrias].

Authors:  P Poblete-Gutiérrez; T Wiederholt; H F Merk; J Frank
Journal:  Hautarzt       Date:  2006-06       Impact factor: 0.751

8.  Pilot study of mitochondrial bioenergetics in subjects with acute porphyrias.

Authors:  Natalia Dixon; Ting Li; Brandon Marion; Denise Faust; Stephen Dozier; Anthony Molina; Sean Rudnick; Herbert L Bonkovsky
Journal:  Mol Genet Metab       Date:  2019-05-20       Impact factor: 4.797

9.  Homozygous variegate porphyria: two similar cases in unrelated families.

Authors:  G M Murphy; J L Hawk; I A Magnus; D F Barrett; G H Elder; S G Smith
Journal:  J R Soc Med       Date:  1986-06       Impact factor: 5.344

Review 10.  [Neurocutaneous porphyrias].

Authors:  J Frank
Journal:  Hautarzt       Date:  2016-03       Impact factor: 0.751

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.